KRS Global Biotechnology, Inc.
503B Outsourcer Of Human Drugs
- UEI
- JWNFEU276LP8
- CAGE
- 691D6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- krsbio.com
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Bulk funding for or prefilled syringes | Medical Command (Army) | $25,000 | |
| Bulk funding for or prefilled syringes | Medical Command (Army) | $25,000 | |
| Fulk funding for or prefilled syringes | Medical Command (Army) | $25,000 | |
| Bulk funding for prefilled syringes | Medical Command (Army) | $25,000 | |
| Bulk funding for prefilled syringes | Medical Command (Army) | $25,000 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
KRS Global Biotechnology, Inc. 503B Outsourcer Of Human Drugs Division is an FDA registered and inspected 503B outsourcing pharmacy and medical device manufacturer providing sterile and non-sterile compounding services to patients, surgery centers, and other medical facilities. The company is a corporate entity registered in SAM.gov since January 2011, though its registration expired in December 2021.
Through prime federal contract awards from the Department of the Army Medical Command, KRS Global Biotechnology, Inc. 503B Outsourcer Of Human Drugs Division provided bulk funding for prefilled syringes over multiple contract calls made against a blanket purchase agreement. These contract calls were made between March and September 2019, each valued at $25,000, with completion dates ranging from April to September 2019. No set-aside designations were used. The work involved providing bulk funding for or prefilled syringes to the Department of the Army Medical Command.
Quick answers
Is KRS Global Biotechnology, Inc. registered in SAM.gov?
KRS Global Biotechnology, Inc.'s SAM.gov registration expired on December 30, 2021.
What is KRS Global Biotechnology, Inc.'s most recent federal award?
KRS Global Biotechnology, Inc.'s most recent federal contract award is Bulk funding for or prefilled syringes (W91YTZ19F0267), from Medical Command (Army), on September 21, 2019.
On GovTribe
See KRS Global Biotechnology, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors